Cytokine regulation of P-glycoprotein
- PMID: 12635814
- DOI: 10.1081/dmr-120018247
Cytokine regulation of P-glycoprotein
Abstract
P-glycoprotein (Pgp) is a membrane bound transporter involved in the disposition of many endogenous compounds and xenobiotics. Alterations in Pgp expression and activity can significantly affect the disposition of Pgp substrates. Infection and inflammatory stimuli have also been shown to alter drug disposition. However, the specific effects of inflammation on Pgp expression and activity are not well understood. This paper evaluates and summarizes the current literature on the effects of cytokines and inflammation on mRNA and protein expression as well as functional activity of Pgp in whole animal models, primary rodent hepatocytes and human carcinoma cell lines.
Similar articles
-
Dual regulation of P-glycoprotein expression by trichostatin A in cancer cell lines.BMC Mol Biol. 2012 Jul 30;13:25. doi: 10.1186/1471-2199-13-25. BMC Mol Biol. 2012. PMID: 22846052 Free PMC article.
-
Keratinocyte growth factor-2 stimulates P-glycoprotein expression and function in intestinal epithelial cells.Am J Physiol Gastrointest Liver Physiol. 2013 Mar 15;304(6):G615-22. doi: 10.1152/ajpgi.00445.2012. Epub 2013 Jan 17. Am J Physiol Gastrointest Liver Physiol. 2013. PMID: 23328208 Free PMC article.
-
Modulation of P-glycoprotein expression by cytochrome P450 3A inducers in male and female rat livers.Biochem Pharmacol. 1998 Feb 15;55(4):387-95. doi: 10.1016/s0006-2952(97)00436-x. Biochem Pharmacol. 1998. PMID: 9514072
-
Regulation of multidrug resistance by pro-inflammatory cytokines.Curr Cancer Drug Targets. 2006 Jun;6(4):295-311. doi: 10.2174/156800906777441753. Curr Cancer Drug Targets. 2006. PMID: 16848721 Review.
-
Regulation of biliary drug efflux pump expression by hormones and xenobiotics.Toxicology. 2001 Oct 5;167(1):37-46. doi: 10.1016/s0300-483x(01)00456-5. Toxicology. 2001. PMID: 11557128 Review.
Cited by
-
Impact of the Genotype and Phenotype of CYP3A and P-gp on the Apixaban and Rivaroxaban Exposure in a Real-World Setting.J Pers Med. 2022 Mar 24;12(4):526. doi: 10.3390/jpm12040526. J Pers Med. 2022. PMID: 35455642 Free PMC article.
-
Modulation of P-glycoprotein at the blood-brain barrier: opportunities to improve central nervous system pharmacotherapy.Pharmacol Rev. 2008 Jun;60(2):196-209. doi: 10.1124/pr.107.07109. Epub 2008 Jun 17. Pharmacol Rev. 2008. PMID: 18560012 Free PMC article. Review.
-
The effects of human immunodeficiency virus infection on the expression of the drug efflux proteins P-glycoprotein and breast cancer resistance protein in a human intestine model.J Pharm Pharmacol. 2015 Feb;67(2):178-88. doi: 10.1111/jphp.12329. Epub 2014 Dec 31. J Pharm Pharmacol. 2015. PMID: 25557407 Free PMC article.
-
Drug access to the central nervous system in Alzheimer's disease: preclinical and clinical insights.Pharm Res. 2015 Mar;32(3):819-39. doi: 10.1007/s11095-014-1522-0. Epub 2014 Oct 16. Pharm Res. 2015. PMID: 25319097 Review.
-
Obesity and Altered Aspirin Pharmacology.Clin Pharmacokinet. 2018 Jun;57(6):663-672. doi: 10.1007/s40262-017-0611-8. Clin Pharmacokinet. 2018. PMID: 29139042 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous